Condition
Alveolar Soft Part Sarcoma clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Alveolar Soft Part Sarcoma clinical trials that are recruiting, at sites in 8 countries (most in United States (3), China (2), Italy (1)). By phase: Phase 2 (2), Phase 1 (2), Phase 3 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 8Countries
Newest Alveolar Soft Part Sarcoma clinical trials
All recruiting trials (7)
-
Benmelstobart plus anlotinib for advanced or inoperable alveolar soft part sarcoma
This trial will test whether combining benmelstobart injections with anlotinib pills helps people aged 14 and older who have advanced or unresectable alveolar soft part sarcoma.
-
GCAR1 CAR-T therapy for GPNMB-expressing solid tumours
This study tests different doses of GCAR1 CAR-T cells in people with specific cancers that make high levels of the GPNMB protein to see if the treatment is safe and how it affects the cancer.
-
Alpha/beta T‑Cell and B‑Cell Depletion plus Zoledronic Acid for Pediatric and Young Adult Solid Tumors
This study will try removing alpha/beta T cells and B cells from donor stem cell grafts and giving zoledronic acid to see if it helps children and young adults (6 months to 25 years) with relapsed or high‑risk solid tumors tolerate allogeneic transplant and reduce relapse.
-
Evaluating the safety of AB122 in patients with advanced solid tumors
This study is testing a new drug called AB122 to see if it's safe for people with advanced solid tumors like pancreatic, colorectal, lung, and gastric cancers.
-
Combining pembrolizumab with local chemotherapy for sarcoma treatment in limbs
This study is testing if combining an immunotherapy drug with local chemotherapy can help people with advanced sarcoma in their limbs live longer without their disease getting worse.
-
Characterizing rare soft tissue sarcomas
This study is trying to learn more about rare types of soft tissue sarcomas by collecting detailed information from 400 patients to help improve treatment options.
-
Phase 3 test of anlotinib (AL3818) versus dacarbazine in advanced alveolar soft part sarcoma, leiomyosarcoma, and synovial sarcoma
This trial tests whether anlotinib (AL3818) helps adults with advanced alveolar soft part sarcoma, while earlier arms compared anlotinib to dacarbazine for leiomyosarcoma and synovial sarcoma that are no longer enrolling.
Related topics
Quick answers
How many Alveolar Soft Part Sarcoma clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 8 countries. The most sites are in United States (3 trials), China (2 trials), Italy (1 trial), Spain (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1: 2, Phase 3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.